The Valley Desk

NCT00994643 · Interventional trial

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Overall registry status Completed

Phase 2

Conditions High Risk Non-Hodgkin's Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov